Search
Eight-year-old Mikayla is the miracle child her parents never thought they would have. They’d tried for seven years to have a baby, and when Mikayla was finally born they couldn’t contain their excitement or pride. The fact she had Down syndrome was secondary.
Our job is to find the answers. It's helping us change kids' lives. See the "why?"s we're asking and answering.
Western Australia’s biggest and only medical research institute dedicated to improving kids’ health and wellbeing, has rebranded to The Kids Research Institute Australia.
Learn how our research is preventing cyberbullying and supporting kids’ mental wellbeing
Hear how one bold idea became a world-leading institute for kids’ health.
Discover how our breakthroughs are helping kids with diabetes live longer, safer lives.
Currently there are no diagnostic tests for ARF, and no treatments targeting immune responses to improve disease outcomes.
The MELODY Study is a Phase 3 randomized, double-blind, placebo-controlled, single-dose study to determine if MEDI8897 will prevent medically attended Respiratory Syncytial Virus (RSV) -confirmed Lower Respiratory Tract Infection (LRTI) in healthy infants entering their first RSV season.
The study is a phase 3, Multicentre, Randomised, Double-blind, Active Comparator-controlled Study to Evaluate the Safety and Tolerability of V114 in Health Infants.
Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical